Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - NET CHANGE IN CASH
Net Change in Cash DNLI - Denali Therapeutics Inc.
-90.9 M
LAST VALUE
34.79%
2 YEAR CAGR
8.32%
5 YEAR CAGR
0.00%
10 YEAR CAGR